News

Applied Clinical Trials Online14h
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor
In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent ...
Applied Clinical Trials Online20h
KEYNOTE-689 Trial Shows Perioperative Keytruda Significantly Improves Survival in Resectable Locally Advanced HNSCC
Results from the Phase III KEYNOTE-689 trial show that adding perioperative Keytruda (pembrolizumab) to standard-of-care radiotherapy improves event-free survival in patients with resectable, locally ...